SBI ALApharma

SBI ALApharma is a Hong Kong-incorporated SBI Group company focused on the global development and commercialization of products based on 5-aminolevulinic acid (5-ALA). It appears to function as an international holding and operating entity within the SBI 5-ALA business, linked to subsidiaries and affiliates including photonamic in Europe and SBI ALApharma Canada. Across the broader SBI ALApharma group, the company is associated with 5-ALA-based photodynamic diagnostics for oncology, including approved and late-stage programs in bladder cancer, ovarian cancer, meningioma, and malignant glioma, as well as investigator-initiated work in ischemia-reperfusion injury. The group also extends 5-ALA into medical devices, health foods, and related healthcare products. Publicly available information suggests the Hong Kong entity is active and serves as part of the international commercialization and development structure for SBI's 5-ALA franchise.